Find the right fit for you - faster
Get tailored insights about working at Freenome in one quick step.
Freenome Snapshot
Freenome is a high growth biotech company on a mission to create tools that empower everyone to prevent, detect, and treat their disease
Approach
To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas.
Funding
We have raised more than $1.1B from leading investors like American Cancer Society's BrightEdge Ventures, Kaiser Permanente, Novartis, Perceptive Advisors, RA Capital Management and Roche, to name a few.
What is a Freenomer?
A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.
Approach
To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas.
Funding
We have raised more than $1.1B from leading investors like American Cancer Society's BrightEdge Ventures, Kaiser Permanente, Novartis, Perceptive Advisors, RA Capital Management and Roche, to name a few.
What is a Freenomer?
A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.
Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a routine blood draw.
